4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BridgeBio Pharma, Inc. (BBIO) operates in the Biotechnology industry and is headquartered in Palo Alto, United States with about 834 employees. Its market capitalization is roughly $16 billion. In the fiscal year ended 2025-12-31, BBIO reported $502M in revenue and ($725M) in net income.
BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
Interactive charts & full statements → Open the BBIO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $502M | $222M | $9M | $78M | — |
| Gross Profit | $481M | $218M | $7M | $74M | — |
| Operating Income (EBIT) | ($502M) | ($577M) | ($599M) | ($468M) | — |
| Net Income | ($725M) | ($536M) | ($643M) | ($481M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $194M | $154M | $121M | $111M | $117M | — |
| Gross Profit | $185M | $146M | $114M | $107M | $114M | — |
| Operating Income (EBIT) | ($106M) | ($128M) | ($136M) | ($134M) | ($104M) | — |
| Net Income | ($164M) | ($193M) | ($183M) | ($182M) | ($167M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $936M | $919M | $546M | $623M | — |
| Total Liabilities | $3.0B | $2.4B | $1.9B | $1.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BBIO viewer.
About TickerBase · Data methodology & sources